Launch One Acquisition Corp. (LPAA)
NASDAQ: LPAA · Real-Time Price · USD
10.73
+0.06 (0.56%)
Feb 27, 2026, 4:00 PM EST - Market closed
5.51% (1Y)
| Market Cap | 308.49M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 9.81M |
| Shares Out | 28.75M |
| EPS (ttm) | 0.33 |
| PE Ratio | 32.00 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 13 |
| Open | n/a |
| Previous Close | 10.67 |
| Day's Range | n/a |
| 52-Week Range | 10.14 - 10.73 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About LPAA
Launch One Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the life sciences sector. The company was incorporated in 2024 and is based in Oakland, California. [Read more]
Industry Shell Companies
Sector Financials
IPO Date Jul 12, 2024
Country United States
Stock Exchange NASDAQ
Ticker Symbol LPAA
News
Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform
New U.S. intellectual property protections expand use of Minovia's leading technology in mitochondrial-based therapies for primary mitochondrial and severe renal diseases New U.S. intellectual propert...
6 weeks ago - GlobeNewsWire